Zymeworks Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Zymeworks Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Zymeworks Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Zymeworks Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
38 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Zymeworks Inc. (Zymeworks) is a biotherapeutics company that develops antibody and protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases. The company also develops technologies in the area of biologics drug discovery and optimization. Zymeworks technology includes ZymeCAD, which is a protein engineering technology platform that develops antibody and antibody alternative products. It also provides other technology platforms such as Azymetric scaffold, AlbuCORE scaffold, EFECT platform, and HL.Max platform. The company caters to pharmaceutical and chemical markets. Zymeworks is headquartered in Vancouver, British Columbia, Canada

Zymeworks Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detai

  
Source:
Document ID
GDPH186157D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Zymeworks Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Zymeworks Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Zymeworks Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Zymeworks Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Zymeworks Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
Zymeworks Inc., Pharmaceuticals &Healthcare, Deal Details1124
  Venture Financing111
    Zymeworks Raises USD61.5 Million in Series A Financing113
    Zymeworks Raises USD4 Million in Venture Financing141
    Zymeworks Raises US$11 Million In Venture Financing151
    Zymeworks Secures Additional US$4 Million In Venture Financing161
    Zymeworks Secures US$8.1 Million In Financing171
    Zymeworks Secures US$3.1 Million In Venture Financing181
  Partnerships191
    ImClone Systems Extends Licensing Agreement with Zymeworks192
    Applied BioMath Partners with Zymeworks211
    Zymeworks Enters into Agreement with Kairos Therapeutics221
    ProBioGen Enters into Agreement with Zymeworks231
    Zymeworks Enters into Research Agreement with University of California, Los Angeles241
    National Research Council Enters into Co-Development Agreement with Zymeworks for Cancer251
  Licensing Agreements261
    Zymeworks Enters into Licensing Agreement with Innovative Targeting Solutions261
    Zymeworks Enters into Licensing Agreement with GlaxoSmithKline272
    Zymeworks Enters into Licensing Agreement with GlaxoSmithKline291
    Zymeworks Enters into Licensing Agreement with Celgene for Bi-Specific Antibody301
    Zymeworks Extends Licensing Agreement with Merck311
    Zymeworks Enters Into Licensing Agreement With Merck321
  Equity Offering331
    Zymeworks Completes Private Placement of Shares for USD17.3 Million331
  Acquisition341
    Zymeworks Acquires Kairos Therapeutics341
Zymeworks Inc. - Key Competitors351
Key Employees361
Locations And Subsidiaries371
  Head Office371
  Other Locations &Subsidiaries371
Appendix381
  Methodology381
  About GlobalData381
  Contact Us381
  Disclaimer381

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Zymeworks Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Zymeworks-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6649>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Zymeworks Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Zymeworks-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6649>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research